Th17细胞和Treg细胞在肝脏疾病中的作用研究进展(6)
[32] Zhao F，Hoechst B，Gamrekelashvili J，et al. Human CCR4+CCR6+Th17 cells suppress autologous CD8+T cell responses [J]. J Immunol，2012，188(12)：6055-6062.
[33] Santini D，Addeo R，Vincenzi B，et al. Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma [J]. Expert Rev Anticancer Ther，2012，12(10)：1283-1288.
[34] Benevides L，Cardoso CR，Tiezzi DG，et al. Enrichment of regulatory T cells in invasive breast tumor correlates with the up regulation of IL-17A expression and invasiveness of the tumor [J]. Eur J Immunol，2013，43(6)：1518-1528.
[35] Liang XS，Li CZ，Zhou Y，et al. Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure [J]. World J Gastroenterol，2014，20(26)：8558-8571.
[36] Shen C，Yan WZ，Zhao CY，et al. Increased CD4+CD25+regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients [J]. J Microbiol Immunol Infect，2015， 48(2)：137-146.
[37] 闞延婷，甘建和，孙蔚，等.HBV相关慢加急性肝衰竭患者Th17、Treg变化及其与临床相关性[J].肝脏，2016， 21(2)：89-91.
[38] 刘茵，王明刚，毛德文，等.解毒化瘀颗粒对肝衰竭大鼠外周CTL、Treg细胞的影响研究[J].时珍国医国药，2018，29(6)：1290-1293.
(收稿日期：2019-05-31 本文编辑：顾家毓), 百拇医药(周小博 张荣臻 陈湘榆)
[33] Santini D，Addeo R，Vincenzi B，et al. Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma [J]. Expert Rev Anticancer Ther，2012，12(10)：1283-1288.
[34] Benevides L，Cardoso CR，Tiezzi DG，et al. Enrichment of regulatory T cells in invasive breast tumor correlates with the up regulation of IL-17A expression and invasiveness of the tumor [J]. Eur J Immunol，2013，43(6)：1518-1528.
[35] Liang XS，Li CZ，Zhou Y，et al. Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure [J]. World J Gastroenterol，2014，20(26)：8558-8571.
[36] Shen C，Yan WZ，Zhao CY，et al. Increased CD4+CD25+regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients [J]. J Microbiol Immunol Infect，2015， 48(2)：137-146.
[37] 闞延婷，甘建和，孙蔚，等.HBV相关慢加急性肝衰竭患者Th17、Treg变化及其与临床相关性[J].肝脏，2016， 21(2)：89-91.
[38] 刘茵，王明刚，毛德文，等.解毒化瘀颗粒对肝衰竭大鼠外周CTL、Treg细胞的影响研究[J].时珍国医国药，2018，29(6)：1290-1293.
(收稿日期：2019-05-31 本文编辑：顾家毓), 百拇医药(周小博 张荣臻 陈湘榆)